- You are here: Home
- Services
- ISH/FISH Services
- FISH Applications
- FISH Quality Control Services
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
FISH Quality Control Services
As Fluorescent in situ hybridization (FISH) is simple, reliable and cost-effective, FISH is a major technology that is applied in diagnosis, especially for hematologic malignancies, even in the area of next-generation sequencing (NGS). The implementation of FISH in the laboratory requires control with attention to when it is appropriate to apply the technology, a systematic approach to the validation of probes, policies and procedures involved. Knowledge of the limitations of any FISH test is required in relation to the probe and tissue being examined, since errors of analysis and interpretation can result in incorrect management. If you want to know your options for FISH quality control in your lab, Creative Bioarray can help you with this! Creative Bioarray has years of experience in performing FISH, cytogenetic services, we can also provide custom FISH quality control service for your lab’s needs!
Figure 1. BCR-ABL1 ES FISH probe localization. The ABL1 probe hybridize to the band level 9q34 (red signals) and the BCR probe to the band level 22q11.2 (green signals) on the DAPI banding (metaphases on the left side), which have been sequentially confirmed by inverted G-Banding (metaphases on the right side)
Figure 2. A BCR-ABL1 fusion positive B-ALL case with an unusual signal pattern of 1R1G1F on the interphase FISH images (middle in the top row) and but the fusion signal on the abnormal chromosome 9 on the metaphase FISH image (left in the top row) indicating that the BCR-ABL1 fusion is caused by insertion of part of the BCR gene into the ABL1 gene in this case.
Applications:
- FISH Program Validation
- Probe Localization
- Next Generation Sequencing (NGS) Quality Control
Features:
- High accuracy and sensitivity
- Fast turnaround time
- Competitive pricing
Creative Bioarray offers FISH Quality Control Services for your scientific research as follows:
- We will help you build your own FISH program which will meet your requirements.
- We can offer slides from slide samples from individuals that will meet your different quality control requirements.
- We can offer FISH probe validation, which ensures that the probe targets its intended chromosome regions.
Quotation and ordering
Our customer service representatives are available 24hr a day! We thank you for choosing Creative Bioarray at your preferred FISH Quality Control Services.
References
- Sugita S.; et al. Practical use and utility of fluorescence in situ hybridization in the pathological diagnosis of soft tissue and bone tumors[J]. Journal of Orthopaedic Science, 2017, 22(4): 601-612.
- Niu X.; et al. Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS[J]. Current treatment options in oncology, 2017, 18(12): 71.
- Quijada-Álamo M.; et al. Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia[J]. Journal of hematology & oncology, 2017, 10(1): 83.
- Dubuc A M.; et al. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG‐stimulated chronic lymphocytic leukemia[J]. American journal of hematology, 2016, 91(10): 978-983.
- Arber DA.; et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127: 2391-2405.
Explore Other Options
For research use only. Not for any other purpose.